Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1035

1.

A reverse translational study on the effect of rituximab, rituximab plus belimumab, or bortezomib on the humoral autoimmune response in SLE.

van Dam LS, Osmani Z, Kamerling SWA, Kraaij T, Bakker JA, Scherer HU, Rabelink TJ, Voll RE, Alexander T, Isenberg DA, van Kooten C, Teng YKO.

Rheumatology (Oxford). 2020 Jan 17. pii: kez623. doi: 10.1093/rheumatology/kez623. [Epub ahead of print]

PMID:
31951278
2.

Neuropsychiatric events in systemic lupus erythematosus: a longitudinal analysis of outcomes in an international inception cohort using a multistate model approach.

Hanly JG, Urowitz MB, Gordon C, Bae SC, Romero-Diaz J, Sanchez-Guerrero J, Bernatsky S, Clarke AE, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Fortin PR, Gladman DD, Bruce IN, Petri M, Ginzler EM, Dooley MA, Ramsey-Goldman R, Manzi S, Jönsen A, Alarcón GS, van Vollenhoven RF, Aranow C, Mackay M, Ruiz-Irastorza G, Lim S, Inanc M, Kalunian KC, Jacobsen S, Peschken CA, Kamen DL, Askanase A, Farewell V.

Ann Rheum Dis. 2020 Jan 8. pii: annrheumdis-2019-216150. doi: 10.1136/annrheumdis-2019-216150. [Epub ahead of print]

PMID:
31915121
3.

Use of direct oral anticoagulants in antiphospholipid syndrome: Reply.

Cohen H, Efthymiou M, Isenberg DA.

J Thromb Haemost. 2020 Jan;18(1):259-261. doi: 10.1111/jth.14674. No abstract available.

PMID:
31894665
4.

Epidemiological profile and north-south gradient driving baseline systemic involvement of primary Sjögren's syndrome.

Brito-Zerón P, Acar-Denizli N, Ng WF, Horváth IF, Rasmussen A, Seror R, Li X, Baldini C, Gottenberg JE, Danda D, Quartuccio L, Priori R, Hernandez-Molina G, Armagan B, Kruize AA, Kwok SK, Kvarnstrom M, Praprotnik S, Sene D, Gerli R, Solans R, Rischmueller M, Mandl T, Suzuki Y, Isenberg D, Valim V, Wiland P, Nordmark G, Fraile G, Bootsma H, Nakamura H, Giacomelli R, Devauchelle-Pensec V, Hofauer B, Bombardieri M, Trevisani VFM, Hammenfors D, Pasoto SG, Retamozo S, Gheita TA, Atzeni F, Morel J, Vollenweider C, Zeher M, Sivils K, Xu B, Bombardieri S, Sandhya P, De Vita S, Minniti A, Sánchez-Guerrero J, Kilic L, van der Heijden E, Park SH, Wahren-Herlenius M, Mariette X, Ramos-Casals M; Sjögren Big Data Consortium.

Rheumatology (Oxford). 2019 Dec 24. pii: kez578. doi: 10.1093/rheumatology/kez578. [Epub ahead of print]

PMID:
31873754
5.

Belimumab after B cell depletion therapy in patients with systemic lupus erythematosus (BEAT Lupus) protocol: a prospective multicentre, double-blind, randomised, placebo-controlled, 52-week phase II clinical trial.

Jones A, Muller P, Dore CJ, Ikeji F, Caverly E, Chowdhury K, Isenberg DA, Gordon C, Ehrenstein MR.

BMJ Open. 2019 Dec 16;9(12):e032569. doi: 10.1136/bmjopen-2019-032569.

6.

Characterization of a Subset of Patients With Rheumatoid Arthritis for Whom Current Management Strategies are Inadequate.

Bradford CM, McDonnell T, Raj D, Robinson GA, Cole A, Ramakrishnan S, González-Serrano R, Mak J, Eskiocak YC, Isenberg DA, Ciurtin C, Jury EC, Manson JJ.

ACR Open Rheumatol. 2019 Apr 22;1(3):145-155. doi: 10.1002/acr2.1021. eCollection 2019 May.

7.

Differential Treatments Based on Drug-induced Gene Expression Signatures and Longitudinal Systemic Lupus Erythematosus Stratification.

Toro-Domínguez D, Lopez-Domínguez R, García Moreno A, Villatoro-García JA, Martorell-Marugán J, Goldman D, Petri M, Wojdyla D, Pons-Estel BA, Isenberg D, Morales-Montes de Oca G, Trejo-Zambrano MI, García González B, Rosetti F, Gómez-Martín D, Romero-Díaz J, Carmona-Sáez P, Alarcón-Riquelme ME.

Sci Rep. 2019 Oct 29;9(1):15502. doi: 10.1038/s41598-019-51616-9.

8.

Prediction of damage accrual in systemic lupus erythematosus using the Systemic Lupus International Collaborating Clinics Frailty Index (SLICC-FI).

Legge A, Kirkland S, Rockwood K, Andreou P, Bae SC, Gordon C, Romero-Diaz J, Sanchez-Guerrero J, Wallace DJ, Bernatsky S, Clarke AE, Merrill JT, Ginzler EM, Fortin PR, Gladman DD, Urowitz MB, Bruce IN, Isenberg DA, Rahman A, Alarcón GS, Petri M, Khamashta MA, Dooley MA, Ramsey-Goldman R, Manzi S, Zoma AA, Aranow C, Mackay M, Ruiz-Irastorza G, Lim SS, Inanc M, van Vollenhoven RF, Jonsen A, Nived O, Ramos-Casals M, Kamen DL, Kalunian KC, Jacobsen S, Peschken CA, Askanase A, Hanly JG.

Arthritis Rheumatol. 2019 Oct 21. doi: 10.1002/art.41144. [Epub ahead of print]

PMID:
31631584
9.

Damage accrual and mortality over long-term follow-up in 300 patients with systemic lupus erythematosus in a multi-ethnic British cohort.

Segura BT, Bernstein BS, McDonnell T, Wincup C, M Ripoll V, Giles I, Isenberg D, Rahman A.

Rheumatology (Oxford). 2019 Oct 19. pii: kez516. doi: 10.1093/rheumatology/kez516. [Epub ahead of print] No abstract available.

PMID:
31630173
10.

Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus.

Enocsson H, Wirestam L, Dahle C, Padyukov L, Jönsen A, Urowitz MB, Gladman DD, Romero-Diaz J, Bae SC, Fortin PR, Sanchez-Guerrero J, Clarke AE, Bernatsky S, Gordon C, Hanly JG, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Ginzler E, Alarcón GS, Chatham WW, Petri M, Khamashta M, Aranow C, Mackay M, Dooley MA, Manzi S, Ramsey-Goldman R, Nived O, Steinsson K, Zoma AA, Ruiz-Irastorza G, Lim SS, Kalunian KC, Inanc M, van Vollenhoven RF, Ramos-Casals M, Kamen DL, Jacobsen S, Peschken CA, Askanase A, Stoll T, Bruce IN, Wetterö J, Sjöwall C.

J Autoimmun. 2020 Jan;106:102340. doi: 10.1016/j.jaut.2019.102340. Epub 2019 Oct 17.

11.

Economic evaluation of damage accrual in an international SLE inception cohort using a multi-state model approach.

Barber MRW, Hanly JG, Su L, Urowitz MB, St Pierre Y, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Petri M, Bruce IN, Dooley MA, Fortin PR, Gladman DD, Sanchez-Guerrero J, Steinsson K, Ramsey-Goldman R, Khamashta MA, Aranow C, Mackay M, Alarcón GS, Manzi S, Nived O, Jönsen A, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Lim SS, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Farewell V, Stoll T, Buyon J, Clarke AE.

Arthritis Care Res (Hoboken). 2019 Oct 14. doi: 10.1002/acr.24092. [Epub ahead of print]

PMID:
31609532
12.

A comparison of three classification criteria sets for Systemic Lupus Erythematosus - a study looking at links to outcome and mortality.

Carneiro AC, Ruiz MM, Freitas S, Isenberg D.

Arthritis Care Res (Hoboken). 2019 Sep 10. doi: 10.1002/acr.24061. [Epub ahead of print]

PMID:
31507091
13.

Adverse infusion reactions to rituximab in systemic lupus erythematosus: a retrospective analysis.

Hennessey A, Lukawska J, Cambridge G, Isenberg D, Leandro M.

BMC Rheumatol. 2019 Aug 29;3:32. doi: 10.1186/s41927-019-0082-7. eCollection 2019.

14.

A case of repetitive myocardial infarction with unobstructed coronaries due to Churg-Strauss syndrome.

Gue YX, Prasad S, Isenberg D, Gorog DA.

Eur Heart J Case Rep. 2019 Jun 1;3(2). pii: ytz041. doi: 10.1093/ehjcr/ytz041.

15.

Peripheral Nervous System Disease in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study.

Hanly JG, Li Q, Su L, Urowitz MB, Gordon C, Bae SC, Romero-Diaz J, Sanchez-Guerrero J, Bernatsky S, Clarke AE, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Fortin PR, Gladman DD, Bruce IN, Petri M, Ginzler EM, Dooley MA, Steinsson K, Ramsey-Goldman R, Zoma AA, Manzi S, Nived O, Jonsen A, Khamashta MA, Alarcón GS, Svenungsson E, van Vollenhoven RF, Aranow C, Mackay M, Ruiz-Irastorza G, Ramos-Casals M, Lim SS, Inanc M, Kalunian KC, Jacobsen S, Peschken CA, Kamen DL, Askanase A, Theriault C, Farewell V.

Arthritis Rheumatol. 2020 Jan;72(1):67-77. doi: 10.1002/art.41070. Epub 2019 Nov 28.

PMID:
31390162
16.

Damage accrual and mortality over long-term follow-up in 300 patients with systemic lupus erythematosus in a multi-ethnic British cohort.

Segura BT, Bernstein BS, McDonnell T, Wincup C, Ripoll V, Giles I, Isenberg D, Rahman A.

Rheumatology (Oxford). 2019 Aug 3. pii: kez292. doi: 10.1093/rheumatology/kez292. [Epub ahead of print]

PMID:
31377781
17.

Using peripheral blood immune signatures to stratify patients with adult and juvenile inflammatory myopathies.

Wilkinson MGL, Radziszewska A, Wincup C, Ioannou Y, Isenberg DA, Manson JJ, Jury EC.

Rheumatology (Oxford). 2020 Jan 1;59(1):194-204. doi: 10.1093/rheumatology/kez252.

PMID:
31292651
18.

Why do some patients with systemic lupus erythematosus fail to respond to B-cell depletion using rituximab?

Freitas S, Mozo Ruiz M, Costa Carneiro A, Isenberg DA.

Clin Exp Rheumatol. 2019 Jul 8. [Epub ahead of print]

PMID:
31287404
19.

Author Correction: New therapies for systemic lupus erythematosus - past imperfect, future tense.

Murphy G, Isenberg DA.

Nat Rev Rheumatol. 2019 Aug;15(8):509. doi: 10.1038/s41584-019-0262-2.

PMID:
31270422
20.

Antiphospholipid antibody levels in early systemic lupus erythematosus: are they associated with subsequent mortality and vascular events?

Pericleous C, D'Souza A, McDonnell T, Ripoll VM, Leach O, Isenberg D, Giles I, Rahman A.

Rheumatology (Oxford). 2020 Jan 1;59(1):146-152. doi: 10.1093/rheumatology/kez239.

21.

Can we validate a clinical score to predict the risk of severe infection in patients with systemic lupus erythematosus? A longitudinal retrospective study in a British Cohort.

Tejera Segura B, Rua-Figueroa I, Pego-Reigosa JM, Del Campo V, Wincup C, Isenberg D, Rahman A.

BMJ Open. 2019 Jun 14;9(6):e028697. doi: 10.1136/bmjopen-2018-028697.

22.

Review of major endocrine abnormalities in patients with systemic lupus erythematosus.

Muñoz C, Isenberg DA.

Clin Exp Rheumatol. 2019 Sep-Oct;37(5):791-796. Epub 2019 Jun 6. Review.

PMID:
31172923
23.

Pain and depression are associated with both physical and mental fatigue independently of comorbidities and medications in primary Sjögren's syndrome.

Hackett KL, Davies K, Tarn J, Bragg R, Hargreaves B, Miyamoto S, McMeekin P, Mitchell S, Bowman S, Price EJ, Pease C, Emery P, Andrews J, Lanyon P, Hunter J, Gupta M, Bombardieri M, Sutcliffe N, Pitzalis C, McLaren J, Cooper A, Regan M, Giles I, Isenberg D, Vadivelu S, Coady D, Dasgupta B, McHugh N, Young-Min S, Moots R, Gendi N, Akil M, Griffiths B, Lendrem DW, Ng WF.

RMD Open. 2019 Apr 24;5(1):e000885. doi: 10.1136/rmdopen-2018-000885. eCollection 2019.

24.

New therapies for systemic lupus erythematosus - past imperfect, future tense.

Murphy G, Isenberg DA.

Nat Rev Rheumatol. 2019 Jul;15(7):403-412. doi: 10.1038/s41584-019-0235-5. Review. Erratum in: Nat Rev Rheumatol. 2019 Aug;15(8):509.

PMID:
31165780
25.

Derivation of a clinical decision instrument to identify patients with status epilepticus who require emergent brain CT.

Isenberg DL, Lin A, Kairys N, Kanter C, Reimer H, Glaze O, Palumbo P, Souiarov G, Fenstermacher R, Gentile N.

Am J Emerg Med. 2019 May 4. pii: S0735-6757(19)30298-0. doi: 10.1016/j.ajem.2019.05.004. [Epub ahead of print]

PMID:
31079976
26.

Letter in response to the 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus by Fanouriakis et al.

Costedoat-Chalumeau N, Isenberg D, Petri M.

Ann Rheum Dis. 2019 May 2. pii: annrheumdis-2019-215573. doi: 10.1136/annrheumdis-2019-215573. [Epub ahead of print] No abstract available.

PMID:
31048291
27.

Present and novel biologic drugs in primary Sjögren's syndrome.

Fasano S, Isenberg DA.

Clin Exp Rheumatol. 2019 May-Jun;37 Suppl 118(3):167-174. Epub 2019 Apr 26. Review.

28.

Construction of a Frailty Index as a Novel Health Measure in Systemic Lupus Erythematosus.

Legge A, Kirkland S, Rockwood K, Andreou P, Bae SC, Gordon C, Romero-Diaz J, Sanchez-Guerrero J, Wallace DJ, Bernatsky S, Clarke AE, Merrill JT, Ginzler EM, Fortin P, Gladman DD, Urowitz MB, Bruce IN, Isenberg DA, Rahman A, Alarcón GS, Petri M, Khamashta MA, Dooley MA, Ramsey-Goldman R, Manzi S, Zoma AA, Aranow C, Mackay M, Ruiz-Irastorza G, Lim SS, Inanc M, van Vollenhoven RF, Jonsen A, Nived O, Ramos-Casals M, Kamen DL, Kalunian KC, Jacobsen S, Peschken CA, Askanase A, Hanly JG.

J Rheumatol. 2020 Jan;47(1):72-81. doi: 10.3899/jrheum.181338. Epub 2019 Apr 15.

PMID:
30988130
29.

Renal transplantation for lupus nephritis: non-adherence and graft survival.

Ntatsaki E, Vassiliou VS, Velo-Garcia A, Salama AD, Isenberg DA.

Lupus. 2019 Apr;28(5):651-657. doi: 10.1177/0961203319842641. Epub 2019 Apr 13.

PMID:
30982400
30.

Presence of anti-rituximab antibodies predicts infusion-related reactions in patients with systemic lupus erythematosus.

Wincup C, Menon M, Smith E, Schwartz A, Isenberg D, Jury EC, Mauri C; ABIRISK Consortium.

Ann Rheum Dis. 2019 Aug;78(8):1140-1142. doi: 10.1136/annrheumdis-2019-215200. Epub 2019 Mar 28. No abstract available.

31.

Aortic Thrombus in a Case of Tertiary Syphilis.

Blome A, Isenberg D.

J Emerg Med. 2019 May;56(5):564-565. doi: 10.1016/j.jemermed.2019.01.017. Epub 2019 Mar 14. No abstract available.

PMID:
30879853
32.

Evaluating the Properties of a Frailty Index and Its Association With Mortality Risk Among Patients With Systemic Lupus Erythematosus.

Legge A, Kirkland S, Rockwood K, Andreou P, Bae SC, Gordon C, Romero-Diaz J, Sanchez-Guerrero J, Wallace DJ, Bernatsky S, Clarke AE, Merrill JT, Ginzler EM, Fortin P, Gladman DD, Urowitz MB, Bruce IN, Isenberg DA, Rahman A, Alarcón GS, Petri M, Khamashta MA, Dooley MA, Ramsey-Goldman R, Manzi S, Steinsson K, Zoma AA, Aranow C, Mackay M, Ruiz-Irastorza G, Lim SS, Inanc M, van Vollenhoven RF, Jonsen A, Nived O, Ramos-Casals M, Kamen DL, Kalunian KC, Jacobsen S, Peschken CA, Askanase A, Hanly JG.

Arthritis Rheumatol. 2019 Aug;71(8):1297-1307. doi: 10.1002/art.40859. Epub 2019 May 29.

PMID:
30771242
33.

Use of combined hormonal contraceptives among women with systemic lupus erythematosus with and without medical contraindications to oestrogen.

Mendel A, Bernatsky S, Pineau CA, St-Pierre Y, Hanly JG, Urowitz MB, Clarke AE, Romero-Diaz J, Gordon C, Bae SC, Wallace DJ, Merrill JT, Buyon J, Isenberg DA, Rahman A, Ginzler EM, Petri M, Dooley MA, Fortin P, Gladman DD, Steinsson K, Ramsey-Goldman R, Khamashta MA, Aranow C, Mackay M, Alarcón G, Manzi S, Nived O, Jönsen A, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Lim S, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Sanchez-Guerrero J, Bruce IN, Costedoat-Chalumeau N, Vinet E.

Rheumatology (Oxford). 2019 Jul 1;58(7):1259-1267. doi: 10.1093/rheumatology/kez014.

PMID:
30753683
34.

Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort.

Wirestam L, Enocsson H, Skogh T, Padyukov L, Jönsen A, Urowitz MB, Gladman DD, Romero-Diaz J, Bae SC, Fortin PR, Sanchez-Guerrero J, Clarke AE, Bernatsky S, Gordon C, Hanly JG, Wallace D, Isenberg DA, Rahman A, Merrill J, Ginzler E, Alarcón GS, Chatham WW, Petri M, Khamashta M, Aranow C, Mackay M, Dooley MA, Manzi S, Ramsey-Goldman R, Nived O, Steinsson K, Zoma A, Ruiz-Irastorza G, Lim S, Kalunian K, Inanc M, van Vollenhoven R, Ramos-Casals M, Kamen DL, Jacobsen S, Peschken C, Askanase A, Stoll T, Bruce IN, Wetterö J, Sjöwall C.

J Rheumatol. 2019 May;46(5):492-500. doi: 10.3899/jrheum.180713. Epub 2019 Jan 15.

35.

Low aspirin use and high prevalence of pre-eclampsia risk factors among pregnant women in a multinational SLE inception cohort.

Mendel A, Bernatsky SB, Hanly JG, Urowitz MB, Clarke AE, Romero-Diaz J, Gordon C, Bae SC, Wallace DJ, Merrill JT, Buyon JP, Isenberg DA, Rahman A, Ginzler EM, Petri M, Dooley MA, Fortin PR, Gladman DD, Steinsson K, Ramsey-Goldman R, Khamashta MA, Aranow C, Mackay M, Alarcón GS, Manzi S, Nived O, Jönsen A, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Lim S, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Sanchez-Guerrero J, Bruce IN, Costedoat-Chalumeau N, Vinet É.

Ann Rheum Dis. 2019 Jul;78(7):1010-1012. doi: 10.1136/annrheumdis-2018-214434. Epub 2018 Dec 20. No abstract available.

36.

Low Percentage of Signal Regulatory Protein α/β+ Memory B Cells in Blood Predicts Development of Anti-drug Antibodies (ADA) in Adalimumab-Treated Rheumatoid Arthritis Patients.

Magill L, Adriani M, Berthou V, Chen K, Gleizes A, Hacein-Bey-Abina S, Hincelin-Mery A, Mariette X, Pallardy M, Spindeldreher S, Szely N, Isenberg DA, Manson JJ, Jury EC, Mauri C.

Front Immunol. 2018 Dec 5;9:2865. doi: 10.3389/fimmu.2018.02865. eCollection 2018.

37.

PEGylated Domain I of Beta-2-Glycoprotein I Inhibits the Binding, Coagulopathic, and Thrombogenic Properties of IgG From Patients With the Antiphospholipid Syndrome.

McDonnell TCR, Willis R, Pericleous C, Ripoll VM, Giles IP, Isenberg DA, Brasier AR, Gonzalez EB, Papalardo E, Romay-Penabad Z, Jamaluddin M, Ioannou Y, Rahman A.

Front Immunol. 2018 Oct 22;9:2413. doi: 10.3389/fimmu.2018.02413. eCollection 2018.

38.

Assessment of Response to B-Cell Depletion Using Rituximab in Cutaneous Lupus Erythematosus.

Quelhas da Costa R, Aguirre-Alastuey ME, Isenberg DA, Saracino AM.

JAMA Dermatol. 2018 Dec 1;154(12):1432-1440. doi: 10.1001/jamadermatol.2018.3793.

39.

Under crossfire: thromboembolic risk in systemic lupus erythematosus.

Ramirez GA, Efthymiou M, Isenberg DA, Cohen H.

Rheumatology (Oxford). 2019 Jun 1;58(6):940-952. doi: 10.1093/rheumatology/key307.

PMID:
30380105
40.

Psychosis in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study.

Hanly JG, Li Q, Su L, Urowitz MB, Gordon C, Bae SC, Romero-Diaz J, Sanchez-Guerrero J, Bernatsky S, Clarke AE, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Fortin PR, Gladman DD, Bruce IN, Petri M, Ginzler EM, Dooley MA, Steinsson K, Ramsey-Goldman R, Zoma AA, Manzi S, Nived O, Jonsen A, Khamashta MA, Alarcón GS, van Vollenhoven RF, Aranow C, Mackay M, Ruiz-Irastorza G, Ramos-Casals M, Lim SS, Inanc M, Kalunian KC, Jacobsen S, Peschken CA, Kamen DL, Askanase A, Theriault C, Farewell V.

Arthritis Rheumatol. 2019 Feb;71(2):281-289. doi: 10.1002/art.40764. Epub 2019 Jan 18.

41.
42.

Antiphospholipid Antibodies to Domain I of Beta-2-Glycoprotein I Show Different Subclass Predominance in Comparison to Antibodies to Whole Beta-2-glycoprotein I.

McDonnell T, Artim-Esen B, Wincup C, Ripoll VM, Isenberg D, Giles IP, Rahman A, Pericleous C.

Front Immunol. 2018 Sep 28;9:2244. doi: 10.3389/fimmu.2018.02244. eCollection 2018.

43.

An evaluation of voclosporin for the treatment of lupus nephritis.

Sin FE, Isenberg D.

Expert Opin Pharmacother. 2018 Oct;19(14):1613-1621. doi: 10.1080/14656566.2018.1516751. Epub 2018 Sep 12. Review.

PMID:
30207816
44.

How immunological profile drives clinical phenotype of primary Sjögren's syndrome at diagnosis: analysis of 10,500 patients (Sjögren Big Data Project).

Brito-Zerón P, Acar-Denizli N, Ng WF, Zeher M, Rasmussen A, Mandl T, Seror R, Li X, Baldini C, Gottenberg JE, Danda D, Quartuccio L, Priori R, Hernandez-Molina G, Armagan B, Kruize AA, Kwok SK, Kvarnström M, Praprotnik S, Sène D, Bartoloni E, Solans R, Rischmueller M, Suzuki Y, Isenberg DA, Valim V, Wiland P, Nordmark G, Fraile G, Bootsma H, Nakamura T, Giacomelli R, Devauchelle-Pensec V, Knopf A, Bombardieri M, Trevisani VF, Hammenfors D, Pasoto SG, Retamozo S, Gheita TA, Atzeni F, Morel J, Vollenveider C, Horvath IF, Sivils KL, Olsson P, De Vita S, Sánchez-Guerrero J, Kilic L, Wahren-Herlenius M, Mariette X, Ramos-Casals M; Sjögren Big Data Consortium.

Clin Exp Rheumatol. 2018 May-Jun;36 Suppl 112(3):102-112. Epub 2018 Aug 14.

45.

1-800-Externship: The Use of Hotlines as a Training Modality for Future Clinicians.

Ling TJ, Percario KN, Hauck JM, Holland EP, Isenberg D, Henawi T, Peters MA, Karahalios J, Messano R.

Community Ment Health J. 2019 Apr;55(3):401-408. doi: 10.1007/s10597-018-0322-0. Epub 2018 Aug 12.

PMID:
30101379
46.

A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered Questionnaires.

Costedoat-Chalumeau N, Houssiau F, Izmirly P, Guern VL, Navarra S, Jolly M, Ruiz-Irastorza G, Baron G, Hachulla E, Agmon-Levin N, Shoenfeld Y, Dall'Ara F, Buyon J, Deligny C, Cervera R, Lazaro E, Bezanahary H, Leroux G, Morel N, Viallard JF, Pineau C, Galicier L, Vollenhoven RV, Tincani A, Nguyen H, Gondran G, Zahr N, Pouchot J, Piette JC, Petri M, Isenberg D.

Clin Pharmacol Ther. 2019 Aug;106(2):374-382. doi: 10.1002/cpt.1194. Epub 2018 Sep 2.

PMID:
30079582
47.

Antinuclear Antibody-Negative Systemic Lupus Erythematosus in an International Inception Cohort.

Choi MY, Clarke AE, St Pierre Y, Hanly JG, Urowitz MB, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Petri M, Bruce IN, Dooley MA, Fortin PR, Gladman DD, Sanchez-Guerrero J, Steinsson K, Ramsey-Goldman R, Khamashta MA, Aranow C, Alarcón GS, Manzi S, Nived O, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Lim SS, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Stoll T, Buyon J, Mahler M, Fritzler MJ.

Arthritis Care Res (Hoboken). 2019 Jul;71(7):893-902. doi: 10.1002/acr.23712. Epub 2019 Jun 12.

PMID:
30044551
48.

A Case of Acute Traumatic Lumbar Paraspinal Compartment Syndrome.

Wasserman DD, Isenberg DL.

J Emerg Med. 2018 Oct;55(4):544-546. doi: 10.1016/j.jemermed.2018.05.030. Epub 2018 Jul 20.

PMID:
30037517
49.

Gene expression profiling identifies distinct molecular signatures in thrombotic and obstetric antiphospholipid syndrome.

Ripoll VM, Pregnolato F, Mazza S, Bodio C, Grossi C, McDonnell T, Pericleous C, Meroni PL, Isenberg DA, Rahman A, Giles IP.

J Autoimmun. 2018 Sep;93:114-123. doi: 10.1016/j.jaut.2018.07.002. Epub 2018 Jul 19.

50.

Simple Changes to Emergency Department Workflow Improve Analgesia in Mechanically Ventilated Patients.

Isenberg DL, Kissman KM, Salinski EP, Saks MA, Evans LB.

West J Emerg Med. 2018 Jul;19(4):668-674. doi: 10.5811/westjem.2018.4.36879. Epub 2018 May 16.

Supplemental Content

Loading ...
Support Center